Company Data
Puma Biotechnology Inc
Ticker
PBYI
Current Price
$9.83 -6.56%
Market Cap
$507.4M
Price Target
Refer to Report
Volume
406.6K
52wk Range
$4.575 - $10.72
Overview
Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.